286 Stock Overview
An investment holding company, provides postpartum care and healthcare services in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Aidigong Maternal & Child Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.84 |
| 52 Week High | HK$14.40 |
| 52 Week Low | HK$1.25 |
| Beta | 0.43 |
| 11 Month Change | -45.88% |
| 3 Month Change | 0% |
| 1 Year Change | -84.92% |
| 33 Year Change | -95.45% |
| 5 Year Change | -92.07% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Aidigong Maternal & Child Health Limited's (HKG:286) 44% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Nov 09
Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now
Sep 25Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%
Jun 06Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper
Mar 22A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)
Jul 06Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Jun 14Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)
Mar 27Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?
Dec 21Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?
Oct 13Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)
Sep 02Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet
Jun 29Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky
Aug 31Do Institutions Own Aidigong Maternal & Child Health Limited (HKG:286) Shares?
Feb 21Is Aidigong Maternal & Child Health Limited's (HKG:286) Stock Price Struggling As A Result Of Its Mixed Financials?
Jan 17
Aidigong Maternal & Child Health's(HKG:286) Share Price Is Down 14% Over The Past Three Years.
Dec 12Shareholder Returns
| 286 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -0.5% | -2.5% | -5.3% |
| 1Y | -84.9% | -22.7% | 11.3% |
Return vs Industry: 286 underperformed the Hong Kong Healthcare industry which returned -22.7% over the past year.
Return vs Market: 286 underperformed the Hong Kong Market which returned 11.3% over the past year.
Price Volatility
| 286 volatility | |
|---|---|
| 286 Average Weekly Movement | 17.6% |
| Healthcare Industry Average Movement | 8.2% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.1% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 286's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 286's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 1,338 | Aier Wang | www.aidigong.hk |
Aidigong Maternal & Child Health Limited, an investment holding company, provides postpartum care and healthcare services in the People’s Republic of China. The company operates through Postpartum Care Services, Health Industry, and Other segments. It offers maternal and child healthcare services; medical anti-aging services; healthcare industry investment services; and healthcare property development services, as well as management, investment, and finance services.
Aidigong Maternal & Child Health Limited Fundamentals Summary
| 286 fundamental statistics | |
|---|---|
| Market cap | HK$353.62m |
| Earnings (TTM) | -HK$192.96m |
| Revenue (TTM) | HK$522.09m |
0.7x
P/S Ratio-1.8x
P/E RatioIs 286 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 286 income statement (TTM) | |
|---|---|
| Revenue | HK$522.09m |
| Cost of Revenue | HK$424.06m |
| Gross Profit | HK$98.03m |
| Other Expenses | HK$290.99m |
| Earnings | -HK$192.96m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.00 |
| Gross Margin | 18.78% |
| Net Profit Margin | -36.96% |
| Debt/Equity Ratio | 78.3% |
How did 286 perform over the long term?
See historical performance and comparison